Table:
begin	end	state
1	12	non-cytoplasmic
13	47	transmembrane
48	58	cytoplasmic
59	80	transmembrane
81	106	non-cytoplasmic
107	131	transmembrane
132	142	cytoplasmic
143	162	transmembrane
163	167	non-cytoplasmic
168	188	transmembrane
189	199	cytoplasmic
200	220	transmembrane
221	261	non-cytoplasmic
262	285	transmembrane
286	324	cytoplasmic
325	346	transmembrane
347	357	non-cytoplasmic
358	381	transmembrane
382	392	cytoplasmic
393	412	transmembrane
413	419	non-cytoplasmic
420	447	transmembrane
448	466	cytoplasmic
467	490	transmembrane
491	506	non-cytoplasmic

Input:
>GFF369
MLELLQQGFGAVFSLNILLLMLGGVAVGIVFGAVPGLSATMAVALCLPLTFTMGPQAGLS
LLVALFIGATSGGLISAILLKIPGTPSSIATVFDGGPLMEQGMGVKALGVGIVFSFLGTI
FSIIALMFIAPQLAKVALSFGPHEYFAIAVFSLTLIATLSAGSMVKGLFAGTLGIAVSTV
GIAPVEAVRRFTFGVSELNGGFSMLTVMIGMFAVAEVIKLAETGRHAVRNKAGSVSMKQI
KGFGFSLKEFRQELPNATRSGLIGLAVGILPGIGAGTSNLLSYIVAKKRAKQPETYGKGN
IGGVVASETANNAGIGGAMMPLMTLGIPGDTTTAILLGGFLIHGIQPGPLLFISQGPLVY
TIFAALLVASVMMLFMEFYGLRLFIKLLDVPKHILLPIILVLCVVGAFGLSSRLFDVWSI
LLFGVLGYGFVKAGMPVAPFIIGFILGPMAETNLRRGLMLSDGNFASFFTNPIAATFLGL
ALAFVLWQLYSAMRPRSGVLGQALRT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server